Expression and activity of ectopeptidases in fibrillating human atria

Journal of Molecular and Cellular Cardiology

Volumn 33, Issue 6, 2001, Pages 1273-1281

  Lendeckel, Uwe ^a   Arndt, Marco ^a   Wrenger, Sabine ^a   Nepple, Karen ^a   Huth, Christof ^a   Ansorge, Siegfried ^a   Klein, Helmut U ^a   Goette, Andreas ^a  

^a UNIVERSITY HOSPITAL MAGDEBURG   (Germany)

Author keywords

Arrhythmia; Bradykinin; Fibrillation; Peptidases; Remodeling

Indexed keywords

CARBOXYPEPTIDASE; DIPEPTIDYL PEPTIDASE IV; MESSENGER RNA; MICROSOMAL AMINOPEPTIDASE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME ANALYSIS; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; MALE; OPEN HEART SURGERY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; RNA ANALYSIS;

EID: 0034961275     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2001.1389     Document Type: Article

References (42)

1. Atrial arrhythmias
2. Epidemiological features of atrial fibrillation: The Framingham Study
3. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
4. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat
5. Histological substrate of atrial biopsies in patients with lone atrial fibrillation
6. Electrical modeling in atrial fibrillation: Time course and mechanisms
7. Experience of 100 atrial endomyocardial biopsy and the concept of atrial cardiomyopathy
8. Promotion of atrial fibrillation by heart failure in dogs. Atrial remodeling of a different sort
9. Chronic rapid atrial pacing: Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation
10. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
11. Cellular mechanisms of cardioprotection afforded by inhibitors of angiotensin converting enzyme in ischemic hearts: Role of bradykinin and nitric oxide
12. Bradykinin mediates cardiac preconditioning at a distance
13. Membrane anchoring and release of carboxypeptidase M: Implications for extracellular hydrolysis of peptide hormones
14. Contribution of angiotensin-converting enzyme to the cardiac metabolism of bradykinin: An interspecies study
15. Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing human hearts
16. Lung peptidases, including carboxypeptidase, modulate airway reactivity to intravenous bradykinin
17. Cardiovascular hypertrophy: Role of angiotensin II and bradykinin
18. Neuropeptide Y: A novel angiogenic factor from the sympathetic nerves and endothelium
19. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum
20. Proline-specific aminopeptidases: Potential role in bradykinin degradation
21. Bradykinin metabolism pathway in the rat pulmonary circulation
22. Role of alanyl aminopeptidase in growth and function of human T cells
23. PC18, a specific aminopeptidase N inhibitor, induces vasopressin release by increasing the half-life of brain angiotensin III
24. Vascular plasma membrane aminoeptidase M. Metabolism of vasoactive peptides
25. Kallidin- and bradykinin-degrading pathways in human heart: Degradation of kallidin by aminopeptidase M-like activity and bradykinin by neutral endopeptidase
26. Regulation of angiotensin II receptor subtypes during atrial fibrillation in humans
27. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
28. Carboxypeptidase M is identical to the MAX.1 antigen and its expression is associated with monocyte to macrophage differentiation
29. Design of the first highly potent and selective aminopeptidase N (EC 3.4.11.2) inhibitor
30. Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation
31. Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide (CGRP), and neuropeptid Y by vascular smooth muscle cells
32. Chronic exercise reduces sympathetic nerve activity in rabbits with pacing-induced heart failure: A role for angiotensin II
33. Inhibition of angiotensin-converting enzyme increases the nitric oxide levels in canine ischemic myocardium
34. Effect of angiotensin-converting-enzyme inhibition on bradykinin metabolism by vascular endothelial cells
35. Late treatment with ramipril increases survival in old spontaneously hypertensive rats
36. Role of kinins and nitric oxide in the antihypertrophic effect of ramipril
37. Contribution of bradykinin to the cardioprotective action of angiotensin converting enzyme inhibition in hypertension and after myocardial infarction
38. Bradykinin metabolism in the postinfarcted rat heart: Role of ACE and neutral endopeptidase 24.11
39. Protective effect of omapatrilat, a vasopeptidase inhibitor, on the metabolism of bradykinin in normal and failing heart
40. Atrial tachycardia-induced remodeling in the presence of a substrate for atrial fibrillation: The whole differs from the sum of its parts
41. Signal transduction underlying arrhythmogenic atrial remodeling due to congestive heart failure
42. Metabolism of bradykinin by the rat coronary vascular bed